This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Daniel Lightwood, PhD
Director, Antibody Discovery at UCB Celltech
Speaker

Profile

After receiving a first class BSc Hons degree at Reading University, UK (1996), I undertook a PhD at the University of Cambridge, Biochemistry Department in the area of protein engineering (graduated 1999). I then joined Celltech (acquired by UCB in 2004) in 1999. During my 15 years at UCB Celltech, I have played a key role in developing UCB’s antibody discovery platform and have been responsible for successfully applying the technology across a number of UCB therapeutic antibody programs. I have recently managed the implementation and launch of a new automated antibody discovery platform. This allows for unparalleled immune sampling and is providing UCB with efficiency savings and results in the generation of very high quality monoclonal antibodies. I currently hold the position of Director, Antibody Discovery at UCB Celltech managing the Core Antibody Discovery team.

Daniel Lightwood, PhD's Network